BATS Chi-X Europe Receives FCA Approval for RIE Status
BATS Chi-X Europe will become an RIE on May 20, 2013. Its initial application was filed with the UK Financial Services Authority in December 2012, before the regulator split into the Financial Conduct Authority (FCA) and other arms in April.
An RIE is an investment exchange recognized by the FCA, under the Financial Services and Markets Act (FSMA). RIEs is exempt from the requirements to hold authorization as an investment house, whereas MTF are not, and may operate both regulated markets for primary listings and MTFs. BATS says that the change will broaden its market traction with buy-side firms and those that are obligated to send orders to RIEs.
"With FCA approval of our RIE application, we will be even better positioned to support the vision of a borderless European capital market and to compete in other areas, such as primary listings," says Mark Hemsley, CEO at BATS Chi-X Europe. "Our RIE status also enables a broader range of retail investors and buy-side firms to connect to our market and enjoy the benefits of competition that the Markets in Financial Instruments Directive allowed, including trading-venue choice, lower fees and improved service and technology."
For a deeper list of similarities and differences between an RIE and an MTF, see this Turquoise-produced document.
Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.
To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe
You are currently unable to print this content. Please contact info@waterstechnology.com to find out more.
You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.
Copyright Infopro Digital Limited. All rights reserved.
As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (point 2.4), printing is limited to a single copy.
If you would like to purchase additional rights please email info@waterstechnology.com
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (clause 2.4), an Authorised User may only make one copy of the materials for their own personal use. You must also comply with the restrictions in clause 2.5.
If you would like to purchase additional rights please email info@waterstechnology.com
More on Regulation
Nasdaq leads push to reform options regulatory fee
A proposed rule change would pare costs for traders, raise them for banks, and defund smaller venues.
The CAT declawed as Citadel’s case reaches end game
The SEC reduced the CAT’s capacity to collect information on investors, in a move that will have knock-on effects for its ongoing funding model case with Citadel.
Waters Wavelength Ep. 305: Cato Institute's Jennifer Schulp
Jennifer joins to discuss what regulatory priorities might look under Paul Atkin's SEC.
Examining Cboe’s lawsuit appealing SEC’s OEMS rule rejection
The Chicago-based exchange has sued the regulator in the Seventh Circuit Court of Appeals after the agency blocked a proposed rule that would change how Silexx is classified.
European exchange data prices surge, new study shows
The report analyzed market data prices and fee structures from 2017 to 2024 and found that fee schedules have increased exponentially. Several exchanges say the findings are misleading.
Regis-TR and the Emir Refit blame game
The reporting overhaul was been marred by problems at repositories, prompting calls to stagger future go-live dates.
FCA: Consolidated tape for UK equities won’t happen until 2028
At an event last week, the FCA proposed a new timeline for the CT, which received pushback from participants, according to sources.
Cusip Global Services wants to know, ‘What’s your damage?’
The evidence and discovery phase of the case against the identifier bureau is set to expire in March, bringing an anticipated jury trial one step closer.
